Product Code: ETC8848116 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for treating parenteral nutrition-associated cholestasis, a liver condition in patients on long-term intravenous nutrition, is relatively niche but important. Growth is influenced by increasing neonatal care services, enhanced diagnostic capabilities, and a rise in premature births requiring long-term parenteral nutrition.
The market for parenteral nutrition-associated cholestasis (PNAC) treatment in the Philippines is driven by the growing number of patients undergoing long-term parenteral nutrition, particularly those with severe gastrointestinal disorders. PNAC is a serious condition that can arise from prolonged use of parenteral nutrition, leading to liver dysfunction. Treatment options include the use of specialized drugs and interventions to prevent or treat liver damage. As healthcare access improves and the awareness of PNAC increases, the demand for effective treatments in the Philippines is expected to grow, with continued focus on improving patient outcomes.
This niche market is hampered by underdiagnosis and lack of awareness among healthcare providers about cholestasis as a complication of long-term parenteral nutrition. Treatment options are expensive and not widely available, especially in public hospitals. There`s also limited access to pediatric parenteral care where the condition is most prevalent.
The Philippines Parenteral Nutrition-Associated Cholestasis (PNAC) Treatment market offers investment opportunities driven by the growing awareness and diagnosis of this condition, which often affects patients undergoing long-term parenteral nutrition therapy. As healthcare access improves and the understanding of PNAC deepens, the demand for effective treatments will rise. Investors in the pharmaceutical sector can explore opportunities to develop and market therapies that address this complication, including liver-protective drugs, nutritional management solutions, and specialized care protocols. This market is poised for growth as treatment advancements continue and healthcare facilities upgrade their capabilities.
The government provides support for the treatment of parenteral nutrition-associated cholestasis through policies that ensure the availability of the necessary medications and treatments in the countrys healthcare system. Policies aim to increase the accessibility of specialized treatments, including reimbursement for healthcare providers who treat this condition.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market - Industry Life Cycle |
3.4 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market - Porter's Five Forces |
3.5 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Trends |
6 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market, By Types |
6.1 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Lipid Injectable Emulsion, 2021- 2031F |
6.1.4 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Fish Oil Triglyceride, 2021- 2031F |
6.1.5 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Ursodeoxycholic Acid, 2021- 2031F |
6.1.6 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.4 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.3 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.4 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Import-Export Trade Statistics |
7.1 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Export to Major Countries |
7.2 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Imports from Major Countries |
8 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Key Performance Indicators |
9 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market - Opportunity Assessment |
9.1 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market - Competitive Landscape |
10.1 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Revenue Share, By Companies, 2024 |
10.2 Philippines Parenteral Nutrition-Associated Cholestasis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |